BioSpace News Archive

The Medical Affairs Professional Society (MAPS) is pleased to announce the launch of the Medical Affairs Launch Excellence Guidance Resource– the second in a series of Standards & Guidance documents developed through collaborative best practice sharing and input by senior Medical Affairs (MA) leaders to further MAPS’ mission of developing industry standards and best practices.

Pulse Biosciences, Inc. announced today that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 23,750 shares of Pulse Biosciences common stock to three new non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on January 15, 2019.

Robert Dworkin, Ph.D. Joins Lotus Clinical Research as Director, Chronic Pain Research to lead Lotus’ chronic pain research programs

Novus Health provides organizations the tools to help individuals and their loved ones live healthier lives.

BD (Becton, Dickinson and Company) announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 22, 2019, at 1 p.m. (ET).

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report fourth quarter and full year 2018 financial results on February 7, 2019.

Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization dedicated to improving health, has been named to Forbes magazine’s 2019 list of America’s Best Employers for Diversity

Astanza Laser is set to host special event, Modern Advancements in Aesthetic Lasers, in Orlando, Florida on February 20, 2019

Ascend Massachusetts, a wholly owned subsidiary of Ascend Wellness Holdings (AWH), announced today that it was awarded the first conditional-use permit for adult-use cannabis retail sales in the city of Boston.

WG Critical Care Launches the First and Only FDA Approved Ready-To-Use Calcium Gluconate in Sodium Chloride Injection